Skip to main content

Table 1 Comparison of clinical parameters between control and IgAN groups

From: Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy

Clinical parameters

Control group

IgAN group

P value

WBC(109/L)

5.69 ± 1.35

6.83 ± 1.78

0.012

Neutrophils(109/L)

3.34 ± 1.24

4.26 ± 1.36

0.014

Lymphocytes(109/L)

1.84 ± 0.44

1.93 ± 0.71

0.549

Hemoglobin(g/L)

140.34 ± 16.64

133.93 ± 17.83

0.137

Platelets(109/L)

230.00 (192.00, 283.50)

230.00 (201.50, 259.00)

0.938

Creatinine (µmol/L)

61.43 ± 13.10

80.29 ± 28.55

0.003

Urea nitrogen (mol/L)

4.63 ± 1.04

5.81 ± 1.82

0.003

Uric acid (µmol/L)

297.57 ± 64.69

370.72 ± 86.03

0.001

Albumin(g/L)

45.35 ± 2.52

40.91 ± 4.59

< 0.001

Total cholesterol(mmol/L)

4.35 ± 0.58

4.93 ± 1.05

0.009

Triglycerides (mmol/L)

1.01 (0.77, 1.33)

1.31 (1.01, 2.18)

0.007

Low-density lipoprotein (mmol/L)

2.51 ± 0.43

2.90 ± 0.77

0.025

Glucose(mmol/L)

4.71 ± 0.43

4.77 ± 0.62

0.580

eGFR(mL/min·1.73 m2)

103.89 (99.40,114.34)

101.95 (72.70, 123.44)

0.380

24-h urine protein (mg/24 h)

--

774.75 (366.18, 2030.60)

--